Stay updated on Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.

Latest updates to the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page
- Check6 days agoChange DetectedAdded Melanoma and related topics (MedlinePlus Genetics). Updated revision to v3.4.3 and removed v3.4.2.SummaryDifference0.3%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRemoved Melanoma and related topics such as MedlinePlus Genetics from the Study Details page.SummaryDifference0.2%

- Check34 days agoChange DetectedSmall editorial updates were made, including adding Melanoma and related topics (MedlinePlus Genetics) and a new revision tag (v3.4.2), while the funding notice and the previous revision tag (v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check41 days agoChange DetectedA general site-wide notice about government funding and NIH status was added, along with a revision tag (Rev. 3.4.1); Melanoma-related topics and MedlinePlus Genetics were removed from related topics.SummaryDifference0.6%

- Check48 days agoChange DetectedIncludes a glossary and related topic links (Melanoma, MedlinePlus Genetics) to improve understanding and navigation of the study details. Adds minor metadata updates, including capitalization normalization of QC criteria text and a revision/version change.SummaryDifference0.4%

- Check56 days agoChange DetectedRevision: v3.3.4 added and v3.3.3 removed.SummaryDifference0.1%

Stay in the know with updates to Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.